The Weight of Cardiovascular Disease

StatusActive, Not Recruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 9 months later Jul 2026 → May 2027
See other at-risk trials from Mayo Clinic

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Jul 2026 to May 2027 Show 5 more changesShow less
    • Enrollment closed, study ongoing
    • Final enrollment: 31 participants (planned 60)
    • Eligibility criteria expanded, about 14 words
    • Secondary endpoints: details revised at 12 of 17 entries
    • Site details revised
  2. Primary and study completion dates: Sep 2025 to Jul 2026v9
  3. Site contact updatedv8
  4. Start date changed from estimate of May 2024 to Apr 22, 2024v7
  5. Start date: Mar 2024 to May 2024v6
Show 4 earlier versionsHide 4 earlier versions
  1. Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v5
  2. Start date: Jan 2024 to Mar 2024
    • Eligibility criteria shortened, about 8 words
    • Secondary endpoints: 18 to 17
    v4
  3. Start date: Nov 2023 to Jan 2024
    • Secondary endpoints: 17 to 18
    v3
  4. Start date: Sep 2023 to Nov 2023v2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Mayo Clinic
1,027 trials monitored
See 130 trials at risk
Heart Disease
8,870 trials monitored
See 440 trials at risk
Obesity
3,909 trials monitored
See 165 trials at risk
The purpose of this study is to evaluate the impact of a cardiometabolic clinic on percent body weight loss, body mass index (BMI), and visceral adiposity distribution in obese adults with cardiovascular disease (CVD) at 12 months.
Trial Details
NCT Number NCT06053645
Lead Sponsor Mayo Clinic
Conditions
(from sponsor)		 Cardiovascular Diseases, Obesity
Related terms Cardiovascular Diseases, Obesity
Enrollment 31 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov